HIV in Indian prisons: risk behaviour, prevalence, prevention & treatment.
Abstract: Background & objectives: HIV is a major health challenge for prison authorities. HIV in prisons has implications for HIV in the general community. The aim of this paper was to gather information on HIV risk, prevalence, prevention and treatment in prisons in India.

Methods: Relevant published and unpublished reports and information were sought in order to provide a coherent picture of the current situation relating to HIV prevention, treatment and care in prisons in India. Information covered prison management and population statistics, general conditions in prisons, provision of general medical care and the HIV situation in prison.

Results: No data on drug injection in prison were identified. Sex between men was reported to be common in some Indian prisons. A national study found that 1.7 per cent of inmates were HIV positive. Some prisons provided HIV education. Condom provision was considered illegal. A few prisoners received drug treatment for drug use, HIV infection or co-infection with sexually transmitted infections (STIs).

Interpretation & conclusions: HIV prevalence in prisons in India was higher than that in the general community. Regular monitoring of information on HIV risk behaviours and prevalence in Indian prisons is strongly recommended. Evidence based treatment for drug injectors and nation-wide provision of HIV prevention strategies are urgently required. Voluntary counselling, testing and treatment for HIV and STIs should be provided.

Key words Drug dependency--harm reduction--HIV--India--prisons--risk behaviour
Article Type: Report
Subject: HIV (Viruses) (Risk factors)
HIV (Viruses) (Prevention)
HIV (Viruses) (Care and treatment)
Prisons (Health aspects)
Prevalence studies (Epidemiology)
Authors: Dolan, Kate
Larney, Sarah
Pub Date: 12/01/2010
Publication: Name: Indian Journal of Medical Research Publisher: Indian Council of Medical Research Audience: Academic Format: Magazine/Journal Subject: Biological sciences; Health Copyright: COPYRIGHT 2010 Indian Council of Medical Research ISSN: 0971-5916
Issue: Date: Dec, 2010 Source Volume: 132 Source Issue: 6
Geographic: Geographic Scope: India Geographic Code: 9INDI India
Accession Number: 247634560
Full Text: In 2008, around 5 million people in Asia were living with HIV. India accounts for about half of these infections (1). Sentinel surveillance conducted by the National AIDS Control Organization (NACO) shows that in the general population HIV prevalence is low (0.25-0.43%), but among high-risk groups, HIV prevalence is much more. In at least five States, HIV prevalence among injecting drug users (IDU) is greater than 10 per cent, with a high of 24 per cent of IDUs are HIV positive in Maharashtra. Prevalence is also elevated among female sex workers and men who have sex with men (2).

Globally, progress has been made in implementing HIV programmes in the community (2); however, HIV prevention, care and treatment have largely been neglected in prisons (3). HIV is a major health challenge for prison authorities (4,5) because substance use disorders6 and injecting drug use (7) are common among incarcerated populations. Subsequently, HIV, viral hepatitis and tuberculosis are more prevalent in prison populations than in the general population (8).

There are an estimated 165,000 IDU in India (9), and it is common for people who use illicit drugs to experience periods in custody (10). However, there are very limited data on the prevalence of drug use or other HIV risk behaviours among Indian prisoners. In a study conducted in 1997-2000, around 8 per cent of individuals admitted to Tihar Jail in Delhi were known to be drug users (11), while in a more recent study of 466 inmates in Delhi, Mumbai and Punjab, 63 per cent reported ever using illicit drugs (12). Despite this uncertainty, it is highly likely that, as in most countries around the world (7), people at high risk of HIV infection are over-represented in Indian prisons.

Prisons do not exist in isolation from the community. The majority of prisoners return to the cities and towns they came from. Resumption of risk behaviours such as unprotected sex (13) and drug abuse (14,15) shortly after release from prison is common. This study was carried out to collect information on HIV risk, prevalence, prevention and treatment programme in prisons in India.

Material & Methods

Relevant published material was searched from 1993 to 2010 and unpublished information from key experts relating to HIV in prisons in India was obtained by request. Specific information included three main areas: (i) Rates of imprisonment; (ii) HIV testing, prevalence and risk behaviours; and (iii) HIV prevention, care and treatment.

The online databases Web of Science, PubMed and Scopus were searched using the search string "(HIV or AIDS or HIV/AIDS) and prison or jail or gaol or correctional and India". Grey literature was accessed by searching the following websites: National Crime Records Bureau http://ncrb.nic.in/; The International Centre for Prison Studies http://www.kcl.ac.uk/schools/ law/research/icps; International AIDS Society http:// www.iasociety.org/; UNAIDS http://www.unaids.org/ en/; UNODC Regional Centre for South Asia http:// www.unodc.org/india/index.html; and WHO Regional Office for South-East Asia http://www.searo.who.int/. Only English-language documents were reviewed.

Where gaps in the data remained, key experts were contacted via e-mail or telephone and requests for specific information were made. Key experts included international agencies, non government organizations (NGOs) working in prisons and/or the community in target countries and officials from relevant government ministries and prison administrative bodies.

Results & Discussion

Prison population: The latest figures available on Indian prison population were 376,396 adult prisoners for 2007 (16), making for an imprisonment rate of 32 per 100,000 of national population (17).

Around two-thirds of inmates were pre-trial detainees (17). A high proportion of pre-trial detainees means a very large inmate turnover. For example, in Tihar Jail, New Delhi, about 12,000 inmates were held while about 60,000 prisoners were admitted and a similar number were discharged annually (17). Indian prisons were overcrowded. Across all correctional facilities, the average occupancy level was 136 per cent16. The three areas with the largest overcrowding were Uttar Pradesh (201%) followed by Chhattisgarh (193%) and Delhi (185%).

HIV risk behaviours: No prevalence data regarding drug use in Indian prisons were identified. Two sources identified denial of the possibility of drug use in prisons as an impediment to addressing HIV in prisons (12,18).

Sex between inmates was reportedly common, at least in one prison (19). In a study conducted in Arthur Road Jail, Mumbai, 72 per cent of a sample of 752 (75 employees and 677 inmates) said that they thought sex between men was common in prisons and 11 per cent engaged in homosexual activity in prison (20).

No evidence was found on the prevalence of tattooing in prisons in India. There were reports from Mumbai of interpersonal violence (involving lacerations, bites and bleeding in two or more participants), which could present risks of HIV transmission (19).

HIV prevalence: No recent HIV prevalence data were identified; existing data were from the mid-to-late 1990s. One national study of HIV prevalence in prisons found that 1.7 per cent of male and 9.5 per cent of female inmates were HIV positive (21). In other studies HIV prevalence in individual prisons ranged from 0.5 to 6.9 per cent (Table). Eighteen of 27 inmates who died at Arthur Road Jail, Mumbai, in a six month period were HIV positive (29). No information on HIV transmission in Indian prisons was found.

HIV prevention: Education: HIV education programmes tended to be ad-hoc and relied on NGOs for facilitation. A sexual health programme, Partnership for Sexual Health, was conducted in 2000 in 11 jails in Andhra Pradesh. Three staff members provided HIV education, counselling, referral and medical treatment (30). The Mumbai District AIDS Control Society and the International Labour Organisation have conducted a workplace HIV prevention programme at the Arthur Road Jail (20). In West Bengal, the Vivekananda International Health Centre has delivered an HIV education programme in 20 prisons reaching 50,000 prisoners and staff (26). In Gujarat, an HIV information and education programme was conducted by NGOs (31).

HIV prevention: Drug dependency treatment: Many prisoners who were placed in drug treatment programmes, were on remand and, therefore, often released before completing treatment (32). Drug offenders received at Tihar Jail, New Delhi were admitted to a de-addiction centre for detoxification and treatment of withdrawal symptoms. A psychiatrist worked with prisoners for approximately one week (33). In 2005, there were three detoxification centres with 72 detoxification beds: 60 for adult males and 12 for adolescents.

After detoxification, drug offenders were segregated and placed in a therapeutic community run by NGOs. As many as 800 prisoners live within the therapeutic communities at Tihar (32,33), where prisoners served as team leaders and supervisors. Staff members such as psychiatrists, psychologists, sociologists and social workers, served as trainers, facilitators and counsellors. Inmates were engaged in counselling, education, meditation, family therapy, anger and grief workshops and recreational activities (32,33).

Tihar Jail hosts the only opioid substitution treatment programme in an Indian prison (34). The programme commenced in 2008; no data on the number of prisoners receiving treatment were reported.

HIV prevention: Harm reduction programmes: A government run prison intervention in Andhra Pradesh included condom distribution (35), but this was stopped as being against prison policy (18). No information regarding bleach distribution was identified and there were no prison based needle and syringe programmes in India (18,36).

HIV care and treatment: Only one source provided information about access to antiretroviral treatment (ART) while in prison. A programme providing legal aid to prisoners had assisted some HIV positive inmates to continue ART while in prison (18).

The present findings revealed that only a few HIV prevention, care and treatment interventions have been implemented in prisons in India. Although no data were located on drug injecting in prison, internationally, injecting drug use is a transmission route for HIV inside prisons (37-40). Two studies reported that sexual activity occurred in prisons. Unprotected sex is an HIV transmission route in prisons (41,42) and the high levels of overcrowding and lack of access to condoms in Indian prisons may be conducive to unprotected sex. Distribution of condoms has previously been disallowed due to legislation against sex between men (43); however, this law was overturned in July 2009 (44). The provision of condoms in prison has been found to be feasible and is not associated with increases in sexual behaviour (45,46).

Some limited, sporadic HIV prevalence data were available, but such data become obsolete rapidly. Regular, nation-wide or State-based collection of HIV/STI prevalence data and information regarding HIV risk behaviours is recommended. This will provide a knowledge base to plan HIV prevention, treatment and care interventions in prison. Such a system could be based on reports available from such surveys conducted in other countries, for example, the Australian National Prison Entrants' Bloodborne Virus Survey (47).

Limited HIV prevention programmes were available in Indian prisons. HIV information, education and communication programmes such as those in prisons in Mumbai, Andhra Pradesh should be expanded to all prisons across the country. Improving access to drug dependency treatment, including scaling-up of opioid substitution treatment, would be another positive step (48). Harm reduction strategies, including condom distribution programmes and needle and syringe programmes, will further assist in reducing the risk of HIV transmission in prison. Several developing countries have introduced methadone maintenance in prison. These countries include Indonesia, Iran and Moldova (48).

Treatment of HIV and STI is also important in stemming HIV in prisons. Voluntary counselling and testing should be promoted and access to HIV and STI treatment improved.

UNODC recommended that the Government of India initiate a process of inquiry in major prisons in India, and where necessary, set up the required facilities for the treatment of drug users (32). Large numbers of prisoners under trial pass through India's prisons each year. Legal reforms to increase non-custodial options for monitoring offenders who have been charged but not yet tried are strongly recommended.

Acknowledgment

Authors acknowledge the World Health Organization SouthEast Asia Regional Office for financial support, and Vivekananda International Health Centre, AASRA and the AIDS awareness Group to provide details on the services they offered to inmates.

Received March 23, 2009

References

(1.) UNAIDS/WHO. AIDS epidemic update-2009. Geneva: Joint United Nations Programme on HIV/AIDS (UNAIDS) and World Health Organization (WHO); 2009.

(2.) UNAIDS. Epidemiological fact sheet on HIV and AIDS: India. 2008; available at: http://www.who.int/globalatlas/ predefinedReports/EFS2008/full/EFS2008_IN.pdf, accessed on March 3, 2009.

(3.) Larney S, Morton P, Dolan K. HIV prevention, treatment and care in prisons in South-East Asia. Sydney: National Drug and Alcohol Research Centre; 2007.

(4.) UNAIDS. Prisons and AIDS: UNAIDS Point of view. Geneva: UNAIDS; 1997.

(5.) UNODC/WHO/UNAIDS. HIV/AIDS Prevention, care, treatment and support in prison settings. Vienna: United Nations Office on Drugs and Crime; 2006.

(6.) Fazel S, Bains P, Doll H. Substance abuse and dependence in prisoners: A systematic review. Addiction 2006; 101 : 18191.

(7.) Dolan K, Kite B, Black E, Aceijas C, Stimson GV; Reference Group on HIV/AIDS Prevention and Care among Injecting Drug Users in Developing and Transitional Countries. HIV in prison in low-income and middle-income countries. Lancet Infect Dis 2007; 7 : 32-41.

(8.) Moller L, Stover H, Jurgens R, Gatherer A, Nikogosian H, editors. Health in prisons: A WHO guide to the essentials in prison health. Copenhagen: WHO Regional Office for Europe; 2007.

(9.) Mathers BM, Degenhardt L, Phillips B, Wiessing L, Hickman M, Strathdee S, et al. Reference Group to the UN on HIV and Injecting Drug Use. Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review. Lancet 2008; 372 : 1733-45.

(10.) UNODC. The extent, patterns and trends of drug abuse in India: National survey. New Delhi: UNODC; 2002.

(11.) Sethi HS. Drug abuse among prison population: A case study of Tihar Jail. New Delhi: Ministry of Social Justice and Empowerment, Government of India and United Nations Office and Drugs and Crime Regional Office for South Asia; 2002.

(12.) UNODC. Prevention of spread of HIV amongst vulnerable groups in South Asia: Our work in South Asian prisons. New Delhi: UNODC; 2008.

(13.) MacGowan RJ, Margolis A, Gaiter J, Morrow K, Zack B, Askew J, et al; Project START Study Group. Predictors of risky sex of young men after release from prison. Int J STD AIDS 2003; 14 : 519-23.

(14.) Dolan K, Wodak A, Hall W, Gaughwin M, Rae F. HIV risk behaviour of IDUs before, during and after imprisonment in New South Wales. Addiction Res 1996; 4 : 151-60.

(15.) National Surveillance Center on Drug Abuse. Annual report on drug abuse of China. Beijing: National Institute on Drug Dependence, Peking University; 2005.

(16.) National Crime Records Bureau. Prison Statistics India 2007. 2009; available at: http://ncrb.nic.in/PSI2007/prison2007. htm, accessed on January 22, 2010.

(17.) International Centre for Prison Studies. Prison Brief: India. 2009. Available at: http://www.kcl.ac.uk/depsta/rel/icps/ worldbrief/continental_asia_records.php?code=94, accessed on January 22, 2010.

(18.) Mansuri S. Incarcerated with HIV--an Asian perspective. Paper presented at XVI International AIDS Conference 2006 August 13-18; Toronto, Canda.

(19.) Donde S. HIV risk behaviour in prisons among drug users in Mumbai. Paper presented at XVI International AIDS Conference 2006 August 13-18; Toronto, Canda

(20.) Palve A, Borges N, Asfar S, Pandit D, Prison employees and inmates, workplace intervention program for risk reduction in prisons. Paper presented at XVI International AIDS Conference 2006; August 13-18, Toronto, Canda.

(21.) Nagaraj S, Sarvade M, Muthanna L, Raju R, Aju S, Sarvade N. HIV seroprevalance and prevalent attitudes amongst the prisoners: A case study in Mysore, Karnataka state India. Paper presented at XIII International AIDS Conference 2000; July 9-14, Durban, South Africa.

(22.) Stubblefield E, Wohl D. Prisons and jails worldwide: Update from the 13th International Conference on AIDS. HEPP News 2000; 3 : 1-3.

(23.) Aggarwal A, Arora U, Nagpal N. Seroprevalence of HIV in Central Jail Inmates of Amritsar. Indian JCommun Med 2005; 30 : 151.

(24.) Sundar M, Ravikumar KK, Sudarshan MK. A cross-sectional seroprevalence survey for HIV-1 and high risk sexual behaviour of seropositives in a prison in India. Indian J Public Health 1995; 39 : 116-8.

(25.) Singh S, Prasad R, Mohanty A. High prevalence of sexually transmitted and blood-borne infections amongst the inmates of a district jail in Northern India. Int JSTD AIDS 1999; 10 : 475-8.

(26.) Nag A, Chattopadhayay D, Nag S, Saha G, VIHC JAILAIDS Group. Prevalence of STDs/HIV infection in prisons of West Bengal and prevention programs in India. Paper presented at XVI International AIDS Conference Toronto 2006 August 1318; Toronto, Canada.

(27.) Pal B, Acharya A, Satyaharayana K. Seroprevalence of HIV infection among jail inmates in Orissa. Indian J Med Res 1999; 109 : 199-201.

(28.) Palaniappan K. Trend of HIV among STD patients, pregnant women and truckers through unlinked anonymous screening in India. Paper presented at 3rd International Conference in AIDS in Asia and the Pacific 1995; Chiang Mai, Thailand.

(29.) Dey J. HIV stalks the Arthur Road Jail. Mumbai Newsline. 19 November 2004.

(30.) Mohammed M. HIV prevention program for prisoners in India: A successful experience. Paper presented at. XIV International AIDS Conference 2002 July 7-12; Barcelona, Spain.

(31.) Pachpinde P. Knowledge and commitment for action in HIV/AIDs prevention in prisons of Gujarat, India. Paper presented at XIV International AIDS Conference 2002 July 7-12; Barcelona, Spain.

(32.) UNODC and Ministry of Social Justice and Empowerment India. Drug abuse among prison population--A case study of Tihar Jail. 2002. Availabe at: http://www.unodc.org/india/ en/drug_abuse_%20prison_population.html, accessed on October 10, 2006.

(33.) Tihar Prisons. Infrastructure in Tihar Prisons. 2006; available at: http://tiharprisons.nic.in/html/infra.htm, accessed on September 12, 2006.

(34.) Department of Tihar Prisons. Medical care and hospital administration. Available at: http://www.delhi.gov.in/wps/ wcm/connect/lib_centraljail/Central+Jail/Home/Medical+C are+and+Hospital+Administration, accessed on January 28, 2010.

(35.) Lingamallu B, Sukumara K, Chandramouli K, Damayanthi K, Dua R, Khosla N, et al. Effective advocacy and involvement: a key to meaningful interventions with prisons and prisoners. Paper presented at XIV International AIDS Conference 2002 July 7-12; Barcelona, Spain.

(36.) Mudur M. India: Campaigners urge check on spread of HIV. BMJ 1995; 310 : 280.

(37.) Dolan K, Hall W, Wodak A, Gaughwin M. Evidence of HIV transmission in an Australian prison. Med J Aust 1994; 160 : 734.

(38.) Jahani MR, Kheirandish P, Hosseini M, Shirzad H, Seyed-Alinaghi SA, Karami N, et al. HIV seroconversion among injection drug users in detention, Tehran, Iran. AIDS 2009; 23 : 538-40.

(39.) Likatavicius G, Uzdaviniene V, Rakickiene J, Caplinskas S, Griskevicius B, Adomoniene B. HIV outbreak in Alytus prison. Paper presented at 4th European Conference on the Methods and Results of Social and Behavioural Research on AIDS 2002; Vilnius.

(40.) Thaisri H, Lerwitworapong J, Vongsheree S, Sawanpanyalert P, Chadbanchachai C, Rojanawiwat A, etal. HIV infection and risk factors among Bangkok prisoners, Thailand: a prospective cohort study. BMC Infect Dis 2003; 3 : 25.

(41.) Adoga MP, Banwat EB, Forbi JC, Nimzing L, Pam CR, Gyar SD, et al. Human immunonodeficiency virus, hepatitis B virus and hepatitis C virus: Sero-prevalence, co-infection and risk factors among prison inmates in Nasarawa State, Nigeria. J Infect Developing Countries 2009; 3 : 539-47.

(42.) Jafa K, McElroy P, Fitzpatrick L, Borkowf CB, Macgowan R, Margolis A, et al. HIV transmission in a state prison system, 1988-2005. PLoS ONE 2009; 4 : 5.

(43.) Singh NK. HIV in prison and consequences outside: The butterfly effect. Sex Transm Dis 2007; 34 : 317.

(44.) Human Rights Watch. India: Court strikes down 'sodomy' law. 2009. Available at: http://www.hrw.org/en/news/2009/07/02/ india-court-strikes-down-sodomy-law, accessed on January 28, 2010.

(45.) Dolan K, Lowe D, Shearer J. Evaluation of the condom distribution program in New South Wales prisons, Australia. J Law Med Ethics 2004; 32 : 124-8.

(46.) Yap L, Butler T, Richters J, Kirkwood K, Grant L, Saxby M, et al. Do condoms cause rape and mayhem? The long-term effects of condoms in New South Wales' prisons. Sex Transm Infect 2007; 83 : 219-22.

(47.) Butler T, Boonwaat L, Hailstone S. National prison entrants' bloodborne virus survey report, 2004. Sydney: Centre for Health Research in Criminal Justice and National Centre in HIV Epidemiology and Clinical Research, University of New South Wales; 2005.

(48.) Larney S. Does opioid substitution treatment in prisons reduce injecting-related HIV risk behaviours? A systematic review. Addiction 2010; 105 : 216-23.

Reprint requests: Dr Kate Dolan, Program of International Research & Training, National Drug & Alcohol Research Centre UNSW, Sydney 2052, NSW, Australia e-mail: K.dolan@unsw.edu.au

Kate Dolan & Sarah Larney

Program of International Research & Training, National Drug & Alcohol Research Centre, University of New South Wales, Sydney, Australia
Table. Information on HIV prevalence in Indian prisons

Location                     Year         Sample
                                          size (N)

Nationally (22)              2000         Unknown
Amritsar Central Jail (23)   2003         500
Central Prison, Bangalore,
  south India (24)           1993         1114
Ghaziabad (25)               1999         249
West Bengal (26)             2000         384
Orissa, 3 prisons (27)       1994-1995    377
Madras (now Chennai) (28)    1995         Unknown
Madurai (28)                 1994-1995    Unknown
Thirunelveli (28)            1995         Unknown

Location                     HIV prevalence (%)

Nationally (22)              1.7 (total) 9.5 (females)
Amritsar Central Jail (23)   2.4
Central Prison, Bangalore,
  south India (24)           1.8 (males)
Ghaziabad (25)               1.3 (inmates aged 15 to 50 yr)
West Bengal (26)             2.3
Orissa, 3 prisons (27)       6.9
Madras (now Chennai) (28)    3.5
Madurai (28)                 4.3 (total) 2 (male) 14.2 (female)
Thirunelveli (28)            0.5

Superscript numerals denote reference numbers
Gale Copyright: Copyright 2010 Gale, Cengage Learning. All rights reserved.